Parkinson’s Disease is often described as a condition where dopamine‑producing neurons slowly die off, but why these neurons are lost has remained one of the biggest unanswered questions in neuroscience. While researchers have long suspected the brain’s immune system plays a role, the exact mechanism has been difficult to pin down.
When we think about Parkinson’s Disease, we often focus on the tremors, stiffness, and slowed movement that shape daily life. But beneath those visible symptoms lies a quieter process: the brain’s struggle to clear out toxic proteins that contribute to neurodegeneration. A newly published study in npj Parkinson’s Disease explores a surprising possible helper in this fight, carbon dioxide, delivered in short, controlled bursts.
Managing Parkinson’s Disease (PD) is a daily balancing act. Medications, especially carbidopa/levodopa, play a huge role in helping you move, stay independent, and feel well. But as symptoms change over time, finding the right dose at the right moment can get tricky.
Plastic is everywhere in our modern world , in food packaging, water bottles, clothing, and household items. Over time, plastic doesn’t truly disappear. Instead, it breaks down into smaller and smaller pieces. Scientists are now studying whether these tiny particles could affect our health, including brain health.
For decades, people living with Parkinson’s Disease, and the caregivers who walk beside them, have known something that science is only now catching up to: sleep is not optional. It is not a luxury or a sign of good self-care. It is a biological requirement, central to how the brain repairs itself, restores balance, and maintains long‑term function.
As our national journey through Mapping the Risk concludes, one thing is clear: Parkinson’s Disease isn’t solely a matter of genetics, it is deeply rooted in where we live, work, and breathe.
